The mortality rate for stomach malignant neoplasms in Brazil is forecasted to remain stable at 6.7 deaths per hundred thousand persons from 2024 through 2028. In 2023, the mortality rate stood at 6.7 as well. Over the last two years, there has been no year-on-year variation, indicating a stable trend. The compound annual growth rate (CAGR) over the last five years also reflects a zero percent change.

Future trends to watch for:

Advances in medical technology and cancer treatment could lower mortality rates.
Public health initiatives aimed at prevention and early diagnosis might influence future trends differently.
Demographic shifts and lifestyle changes could also impact mortality statistics.